Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States
Hamid Badali, Connie Cañete‐Gibas, Dora I. McCarthy, Hoja Patterson, Carmita Sanders, Marjorie David, James Mele, Hongxin Fan, Nathan P. Wiederhold
Abstract
species (GM MIC of 1.30 μg/ml). In head-to-head comparisons, the most active azole was posaconazole, followed by isavuconazole. Differences in azole and amphotericin B susceptibility patterns were observed between the genera with the greatest variability observed with isavuconazole. Awareness of the epidemiology of Mucorales isolates and differences in antifungal susceptibility patterns in the United States may aide clinicians in choosing antifungal treatment regimens. Further studies are warranted to correlate these findings with clinical outcomes.
Topics & Concepts
MucormycosisEpidemiologyIncidence (geometry)AntifungalBiologyMycosisMycologyMedicineMicrobiologyImmunologyInternal medicinePathologyOpticsPhysicsPaleontologyAntifungal resistance and susceptibilityFungal Infections and StudiesFungal Biology and Applications